Compounds > 2-(n,n-dipropyl)amino-5,6-dihydroxytetralin
Page last updated: 2024-09-03

2-(n,n-dipropyl)amino-5,6-dihydroxytetralin and cardiovascular agents

2-(n,n-dipropyl)amino-5,6-dihydroxytetralin has been researched along with cardiovascular agents in 1 studies

Compound Research Comparison

Studies
(2-(n,n-dipropyl)amino-5,6-dihydroxytetralin)		Trials
(2-(n,n-dipropyl)amino-5,6-dihydroxytetralin)		Recent Studies (post-2010)
(2-(n,n-dipropyl)amino-5,6-dihydroxytetralin)		Studies
(cardiovascular agents)		Trials
(cardiovascular agents)		Recent Studies (post-2010) (cardiovascular agents)
370017,6451,4806,891

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldberg, LI; Kohli, JD; McDermed, JD1

Other Studies

1 other study(ies) available for 2-(n,n-dipropyl)amino-5,6-dihydroxytetralin and cardiovascular agents

ArticleYear
Modification of cardiovascular actions of 2-amino-5,6-dihydroxytetralin by N,N-di-n-propyl substitution.
    European journal of pharmacology, 1982, Jul-09, Volume: 81, Issue:2

    Topics: Adrenergic alpha-Agonists; Animals; Cardiovascular Agents; Dogs; Dopamine; Femoral Artery; Heart Rate; Myocardial Contraction; Naphthalenes; Receptors, Dopamine; Renal Circulation; Structure-Activity Relationship; Sulpiride; Tetrahydronaphthalenes

1982